Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Opthea (OPT) News Today

Opthea logo

OPT Latest News

Opthea to host corporate update webinar
Opthea Provides Corporate Update
Opthea Limited (CKDXF) was downgraded to a Sell Rating at Bell Potter
Opthea Ends Development of Sozinibercept in Wet AMD
Opthea terminates COAST trial, announces ShORe trial misses endpoint
Opthea Announces Decision to Discontinue Wet AMD Trials
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
Opthea double downgraded to Underperform from Buy at Jefferies
Opthea Announces COAST Phase 3 Trial Topline Results
Opthea Announces Phase 2b Wet AMD Publication
Opthea announces anticipated milestones
Opthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last year
Opthea Reports Half Year Results and Business Updates
Opthea Completes Drug Product PPQ Campaign
Get Opthea News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Videos

Tech Rally, Stock Picks & Live Analysis

OPT Media Mentions By Week

OPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPT
News Sentiment

-0.54

0.56

Average
Medical
News Sentiment

OPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPT Articles
This Week

0

0

OPT Articles
Average Week

Get the Latest News and Ratings for OPT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Opthea and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:OPT) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners